- Aug. 4-10, 2022 COVID-19 update: 14 deaths, 3,189 new infections in Hawaiʻi – Maui Nowon August 13, 2022 at 8:03 pm
- Biopharmaceutical Stocks Continue To Perform Well; Many Attractive Values Remaining – Seeking Alphaon August 13, 2022 at 10:22 am
- Government mulls second booster shots for elderly and comorbid people – The Kathmandu Poston August 13, 2022 at 2:27 am
- A Guide to Novavax’s COVID-19 Vaccine – FactCheck.orgon August 12, 2022 at 10:39 pm
- Vaxxinity CEO on COVID: The market isn’t going away and it’s going to be a massive commercial opportunity – Yahoo Financeon August 12, 2022 at 8:19 pm
- Seagen, after $42M victory, suffers loss in ADC patent feud with Daiichi – FiercePharmaon August 12, 2022 at 7:25 pm
- Pfizer shows key data, setting up pediatric nod for Prevnar 20 – FiercePharmaon August 12, 2022 at 3:35 pm
- Vaccination May Prevent Severe COVID-19 in Patients With Lung Cancer – Cancer Therapy Advisoron August 12, 2022 at 2:00 pm
- Enhertu receives landmark HER2-low breast cancer approval – FiercePharmaon August 12, 2022 at 1:53 pm
- Amgen is the latest drugmaker in Senate committee’s tax probe – FiercePharmaon August 12, 2022 at 1:06 pm